Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
104 participants
INTERVENTIONAL
2003-03-31
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: To determine the impact of spinal manipulation on pain and analgesic use in acute low back pain.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients: Outpatients with acute low back pain. Setting: Emergency Department of Bern University Hospital and a primary care practice network.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
manipulative therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Duration of acute low back pain less than 4 weeks
3. Informed consent
Exclusion Criteria
2. Radicular origin of back pain (with irradiation)
3. Cauda equine syndrome
4. Neurologic deficit
5. Epidural glucocorticoid injections in the preceding three months
6. Previous low back surgery
7. Severe osteoporosis
8. Blood-coagulation disorder
9. Allergy to planned rescue medications
10. Suspicion of a specific cause of low back pain (fracture, tumor, infection, inflammatory disease of the spine, HIV-infection) in the patient's history or by physical examination
11. History or signs of severe dysfunction of the liver or kidney
20 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss Society for Manual Therapy (SAMM)
UNKNOWN
Insel Gruppe AG, University Hospital Bern
OTHER
Wissenschaftlicher Fonds WFR
UNKNOWN
University of Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Bern
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter M. Villiger, MD
Role: PRINCIPAL_INVESTIGATOR
Dep. of Rheumatology & Clinical Immunology/Allergology, University Hospital of Berne
Peter Juni, MD
Role: STUDY_DIRECTOR
Department of Social and Preventive Medicine (ISPM), University of Berne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Social and Preventive Medicine (ISPM), University of Bern
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INSEL749
Identifier Type: -
Identifier Source: secondary_id
KEK220_02
Identifier Type: -
Identifier Source: org_study_id